pharma news today obesity drugs glp-1 today ๐ The next trillion-dollar drug war has begun Drugmakers including Eli Lilly, Novo Nordisk, Pfizer, Amgen, AstraZeneca and others are racing beyond today's drugs. New pills, monthly injections and next-generation pharma news today glp-1 obesity
Description
Endocrinology 2003
doi: 10.1093/ckj/sfae296
doi: 10.1016/j.brainres.2018.11.007 64 ZhangLQZhangWLiTYangTYuanXZhouYet al
For cash-pay patients, the distinction matters less since Novo Nordisk offers both at the same $349/month cash price
4 Cardiovascular Risk Reduction In addition to managing blood glucose levels and promoting weight loss, GLP-1 receptor agonists have been found to reduce the risk of cardiovascular events, which is a critical consideration in diabetic patients
[DOI] [PubMed] [Google Scholar] 935.Norregaard P.K., Deryabina M.A., Tofteng Shelton P., Fog J.U., Daugaard J.R., Eriksson P.O
